Rapamycin for Longevity: What the PEARL Trial Actually Found After 48 Weeks in Humans
114 adults, 48 weeks, placebo-controlled: the first rigorous human rapamycin longevity trial found a 5% lean mass gain in women and a favorable safety profile.
114 adults, 48 weeks, placebo-controlled: the first rigorous human rapamycin longevity trial found a 5% lean mass gain in women and a favorable safety profile.
The largest human trials — 296,707 participants across 78 RCTs — show antioxidant supplements increase mortality, not reduce it. Here is what the data actually says, and what works instead.
TL;DR: When the same blood sample was run twice, six widely used epigenetic clocks disagreed with themselves by as much as 9 years (Higgins-Chen, Nature…
Can you really turn back the clock just by lifting weights? According to cutting-edge research, the answer is a resounding yes. Strength training 2–3 times…